{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:24:29Z","timestamp":1794014669590,"version":"4.8.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007949","name":"Swedish Rheumatism Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010805","name":"Forskningsr\u00e5det i Syd\u00f6stra Sverige","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010805","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016670","name":"Region \u00d6sterg\u00f6tland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2017-00359"],"award-info":[{"award-number":["2017-00359"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007857","name":"Foundation King Gustaf V 80-\u00e5rsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jtauto.2025.100317","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T18:46:46Z","timestamp":1758134806000},"page":"100317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Serum test for secretory component-containing anti-citrullinated protein antibodies as a novel prognostic tool in rheumatoid arthritis at-risk subjects"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4492-9172","authenticated-orcid":false,"given":"Klara","family":"Martinsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"\u00c5hammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0009-7345","authenticated-orcid":false,"given":"Alexandra","family":"C\u00eerciumaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bence","family":"R\u00e9thi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ziegelasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7669-3777","authenticated-orcid":false,"given":"Aase","family":"Hensvold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7187-1477","authenticated-orcid":false,"given":"Alf","family":"Kastbom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2025.100317_bib1","article-title":"Are there causal mucosal drivers in the preclinical development of rheumatoid arthritis?","author":"Holers","year":"2023","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2025.100317_bib2","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/art.42549","article-title":"Rheumatoid arthritis-specific Autoimmunity in the lung before and at the onset of disease","volume":"75","author":"Joshua","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100317_bib3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/path.1877","article-title":"The function of immunoglobulin A in immunity","volume":"208","author":"Woof","year":"2006","journal-title":"J. Pathol."},{"key":"10.1016\/j.jtauto.2025.100317_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13075-016-1014-1","article-title":"Circulating secretory IgA antibodies against cyclic citrullinated peptides in early rheumatoid arthritis associate with inflammatory activity and smoking","volume":"18","author":"Roos","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2025.100317_bib5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/annrheumdis-2018-213724","article-title":"Secretory form of rheumatoid arthritis-associated autoantibodies in serum are mainly of the IgM isotype, suggesting a continuous reactivation of autoantibody responses at mucosal surfaces","volume":"78","author":"van Delft","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2025.100317_bib6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13075-020-02363-0","article-title":"Presence of salivary IgA anti-citrullinated protein antibodies associate with higher disease activity in patients with rheumatoid arthritis","volume":"22","author":"Roos Ljungberg","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2025.100317_bib7","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/rheumatology\/kez377","article-title":"Secretory anti-citrullinated protein antibodies in serum associate with lung involvement in early rheumatoid arthritis","volume":"59","author":"Roos Ljungberg","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2025.100317_bib8","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1093\/rheumatology\/keae146","article-title":"Identification of early risk factors for anti-citrullinated-protein-antibody positive rheumatoid arthritis-a prospective cohort study","volume":"11","author":"C\u00eerciumaru","year":"2024","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2025.100317_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/03009742.2020.1818820","article-title":"Autoantibodies are major predictors of arthritis development in patients with anti-citrullinated protein antibodies and musculoskeletal pain","volume":"50","author":"Eloff","year":"2021","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100317_bib10","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/art.41402","article-title":"Third-generation anti-cyclic citrullinated peptide antibodies improve prediction of clinical arthritis in individuals at risk of rheumatoid arthritis","volume":"72","author":"Di Matteo","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100317_bib11","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/rheumatology\/kex340","article-title":"The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia","volume":"56","author":"Ten Brinck","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2025.100317_bib12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/cei.13591","article-title":"Circulating anti-citrullinated protein antibodies containing secretory component are prognostic for arthritis onset in at-risk patients","volume":"204","author":"Roos Ljungberg","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtauto.2025.100317_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2025.100291","article-title":"Autoantibodies as prognostic markers in rheumatoid arthritis","volume":"10","author":"Turesson","year":"2025","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.jtauto.2025.100317_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13075-016-1014-1","article-title":"Circulating secretory IgA antibodies against cyclic citrullinated peptides in early rheumatoid arthritis associate with inflammatory activity and smoking","volume":"18","author":"Roos","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2025.100317_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1084\/jem.20071204","article-title":"Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease","volume":"205","author":"Matysiak-Budnik","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jtauto.2025.100317_bib16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/art.42044","article-title":"Extramucosal Formation and prognostic value of secretory antibodies in rheumatoid arthritis","volume":"74","author":"Martinsson","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100317_bib17","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/rheumatology\/kez348","article-title":"Elevated free secretory component in early rheumatoid arthritis and prior to arthritis development in patients at increased risk","volume":"59","author":"Martinsson","year":"2020","journal-title":"Rheumatology"}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909025000528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909025000528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T17:32:59Z","timestamp":1773163979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909025000528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":17,"alternative-id":["S2589909025000528"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2025.100317","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum test for secretory component-containing anti-citrullinated protein antibodies as a novel prognostic tool in rheumatoid arthritis at-risk subjects","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2025.100317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100317"}}